These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 38006691)
1. Gut microbiome predicts gastrointestinal toxicity outcomes from chemoradiation therapy in patients with head and neck squamous cell carcinoma. Hes C; Desilets A; Tonneau M; El Ouarzadi O; De Figueiredo Sousa M; Bahig H; Filion É; Nguyen-Tan PF; Christopoulos A; Benlaïfaoui M; Derosa L; Alves Costa Silva C; Ponce M; Malo J; Belkad W; Charpentier D; Aubin F; Hamilou Z; Jamal R; Messaoudene M; Soulières D; Routy B Oral Oncol; 2024 Jan; 148():106623. PubMed ID: 38006691 [TBL] [Abstract][Full Text] [Related]
2. Efficacy of beta-hydroxy-beta-methylbutyrate, arginine, and glutamine for the prevention of mucositis induced by platinum-based chemoradiation in head and neck cancer: A phase II study. Kuroki K; Rikimaru F; Kunitake N; Toh S; Higaki Y; Masuda M Clin Nutr ESPEN; 2023 Oct; 57():730-734. PubMed ID: 37739730 [TBL] [Abstract][Full Text] [Related]
4. Disease-induced and treatment-induced alterations in body composition in locally advanced head and neck squamous cell carcinoma. Willemsen ACH; Hoeben A; Lalisang RI; Van Helvoort A; Wesseling FWR; Hoebers F; Baijens LWJ; Schols AMWJ J Cachexia Sarcopenia Muscle; 2020 Feb; 11(1):145-159. PubMed ID: 31536685 [TBL] [Abstract][Full Text] [Related]
5. A multicenter phase II trial of paclitaxel, carboplatin, and cetuximab followed by chemoradiotherapy in patients with unresectable locally advanced squamous cell carcinoma of the head and neck. Enokida T; Ogawa T; Homma A; Okami K; Minami S; Nakanome A; Shimizu Y; Maki D; Ueda Y; Fujisawa T; Motegi A; Ohkoshi A; Taguchi J; Ebisumoto K; Nomura S; Okano S; Tahara M Cancer Med; 2020 Mar; 9(5):1671-1682. PubMed ID: 31943834 [TBL] [Abstract][Full Text] [Related]
6. A phase 1 trial of Vorinostat in combination with concurrent chemoradiation therapy in the treatment of advanced staged head and neck squamous cell carcinoma. Teknos TN; Grecula J; Agrawal A; Old MO; Ozer E; Carrau R; Kang S; Rocco J; Blakaj D; Diavolitsis V; Kumar B; Kumar P; Pan Q; Palettas M; Wei L; Baiocchi R; Savvides P Invest New Drugs; 2019 Aug; 37(4):702-710. PubMed ID: 30569244 [TBL] [Abstract][Full Text] [Related]
7. Distinctive mucositis and feeding-tube dependency in cetuximab plus radiotherapy for head and neck cancer. Yokota T; Onoe T; Ogawa H; Hamauchi S; Iida Y; Kamijo T; Suda T; Yurikusa T; Nishimura T; Yasui H; Onitsuka T Jpn J Clin Oncol; 2015 Feb; 45(2):183-8. PubMed ID: 25420692 [TBL] [Abstract][Full Text] [Related]
8. Role of concomitant chemoradiation in locally advanced head and neck cancers. Lasrado S; Moras K; Pinto GJ; Bhat M; Hegde S; Sathian B; Luis NA Asian Pac J Cancer Prev; 2014; 15(10):4147-52. PubMed ID: 24935361 [TBL] [Abstract][Full Text] [Related]
9. Comparison of acute toxicities associated with cetuximab-based bioradiotherapy and platinum-based chemoradiotherapy for head and neck squamous cell carcinomas: A single-institution retrospective study in Japan. Sakashita T; Homma A; Hatakeyama H; Furusawa J; Kano S; Mizumachi T; Iizuka S; Onimaru R; Tsuchiya K; Yasuda K; Shirato H; Fukuda S Acta Otolaryngol; 2015 Aug; 135(8):853-8. PubMed ID: 25814008 [TBL] [Abstract][Full Text] [Related]
10. Phase 1 dose-finding study of metformin in combination with concurrent cisplatin and radiotherapy in patients with locally advanced head and neck squamous cell cancer. Gulati S; Desai J; Palackdharry SM; Morris JC; Zhu Z; Jandarov R; Riaz MK; Takiar V; Mierzwa M; Gutkind JS; Molinolo A; Desai PB; Sadraei NH; Wise-Draper TM Cancer; 2020 Jan; 126(2):354-362. PubMed ID: 31626727 [TBL] [Abstract][Full Text] [Related]
11. TGFbeta1 genetic polymorphism is associated with survival in head and neck squamous cell carcinoma independent of the severity of chemoradiotherapy induced mucositis. Lundberg M; Saarilahti K; Mäkitie AA; Mattila PS Oral Oncol; 2010 May; 46(5):369-72. PubMed ID: 20308003 [TBL] [Abstract][Full Text] [Related]
12. Baseline gut microbiota composition is associated with oral mucositis and tumour recurrence in patients with head and neck cancer: a pilot study. Al-Qadami G; Bowen J; Van Sebille Y; Secombe K; Dorraki M; Verjans J; Wardill H; Le H Support Care Cancer; 2023 Jan; 31(1):98. PubMed ID: 36607434 [TBL] [Abstract][Full Text] [Related]
13. Transitions in oral and gut microbiome of HPV+ oropharyngeal squamous cell carcinoma following definitive chemoradiotherapy (ROMA LA-OPSCC study). Oliva M; Schneeberger PHH; Rey V; Cho M; Taylor R; Hansen AR; Taylor K; Hosni A; Bayley A; Hope AJ; Bratman SV; Ringash J; Singh S; Weinreb I; Perez-Ordoñez B; Chepeha D; Waldron J; Xu W; Guttman D; Siu LL; Coburn B; Spreafico A Br J Cancer; 2021 Apr; 124(9):1543-1551. PubMed ID: 33750907 [TBL] [Abstract][Full Text] [Related]
14. Feasibility and toxicity of concurrent chemoradiation for elderly patients with head and neck cancer. Daly ME; Lau DH; Farwell DG; Luu Q; Donald PJ; Chen AM Am J Otolaryngol; 2013; 34(6):631-5. PubMed ID: 23954137 [TBL] [Abstract][Full Text] [Related]
15. Initial analysis of the synergy of programmed cell death-1 (PD-1) inhibitor and concurrent chemoradiotherapy treatment for recurrent/metastatic head and neck squamous cell carcinoma patients. Li L; Chen L; Yan L; Guo Y; Li F; Fan M; Lan M; Lai X; Zhou J; Huang Y; Xu P; Lang J; Feng M Radiat Oncol; 2023 Jul; 18(1):109. PubMed ID: 37403098 [TBL] [Abstract][Full Text] [Related]
16. Survival outcomes with concurrent chemoradiation for elderly patients with locally advanced head and neck cancer according to the National Cancer Data Base. Amini A; Jones BL; McDermott JD; Serracino HS; Jimeno A; Raben D; Ghosh D; Bowles DW; Karam SD Cancer; 2016 May; 122(10):1533-43. PubMed ID: 26969811 [TBL] [Abstract][Full Text] [Related]
17. A phase Ⅱ prospective trial of photobiomodulation therapy in limiting oral mucositis in the treatment of locally advanced head and neck cancer patients. Taylor JK; Mady LJ; Baddour K; Iheagwara UK; Zhai S; Ohr JP; Zandberg DP; Gorantla VC; Ferris RL; Kim S; Duvvuri U; Kubik MW; Sridharan S; Johnson JT; Holeva KD; Quinn AE; Clump DA World J Otorhinolaryngol Head Neck Surg; 2022 Dec; 8(4):345-354. PubMed ID: 36474663 [TBL] [Abstract][Full Text] [Related]
18. Correlation of planning target volume with mucositis for head-and-neck cancer patients undergoing chemoradiation. Manur JG; Vidyasagar N J Cancer Res Ther; 2020; 16(3):565-568. PubMed ID: 32719268 [TBL] [Abstract][Full Text] [Related]
19. Oral mucositis prevention by low-level laser therapy in head-and-neck cancer patients undergoing concurrent chemoradiotherapy: a phase III randomized study. Gouvêa de Lima A; Villar RC; de Castro G; Antequera R; Gil E; Rosalmeida MC; Federico MH; Snitcovsky IM Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):270-5. PubMed ID: 21163585 [TBL] [Abstract][Full Text] [Related]
20. Study of functional infrared imaging for early detection of mucositis in locally advanced head and neck cancer treated with chemoradiotherapy. Cohen EE; Ahmed O; Kocherginsky M; Shustakova G; Kistner-Griffin E; Salama JK; Yefremenko V; Novosad V Oral Oncol; 2013 Oct; 49(10):1025-31. PubMed ID: 23988569 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]